36 results
6-K
EX-99.2
PBM
Psyence Biomedical Ltd. Warrant
20 Sep 24
Share Purchase and Sale Agreement
5:00pm
” to affirm Psyence Biomed’s commitment to an evidence-based approach to innovation as it works to develop safe and effective, FDA-approved, nature
6-K
EX-99.1
PBM
Psyence Biomedical Ltd. Warrant
13 Sep 24
Psyence Biomedical Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq
5:00pm
medicine to be listed on Nasdaq. The name “Psyence” combines the words “psychedelics” and “science” to affirm Psyence Biomed’s commitment to an evidence
6-K
EX-99.2
PBM
Psyence Biomedical Ltd. Warrant
5 Sep 24
Current report (foreign)
4:31pm
agreement with PsyLabs demonstrates our commitment to advance the highest quality psilocybin candidate into clinical development.”
“At PsyLabs, we have … ” and “science” to affirm Psyence Biomed’s commitment to an evidence-based approach to innovation as it works to develop safe and effective, nature-derived
6-K
EX-99.1
PBM
Psyence Biomedical Ltd. Warrant
30 Aug 24
Current report (foreign)
4:06pm
or subscribe for or enter into any contract or make any other commitment whatsoever in relation to any securities of the Company. No representation
424B3
PBM
Psyence Biomedical Ltd. Warrant
30 Aug 24
Prospectus supplement
4:00pm
Lion Commitment Period (as defined below) under the White Lion Purchase Agreement (assuming the shares to be issued are sold at a price of $0.50 per … share and (b) 375,000 Common Shares (the “Commitment Shares”) issuable to White Lion as consideration for entering into the White Lion Purchase Agreement
F-1
nf13cpcvy4 tzxzdic
19 Aug 24
Registration statement (foreign)
4:07pm
424B3
w5zu 1p6y4e0bu
19 Aug 24
Prospectus supplement
9:27am
POS AM
vcbsxlf8shnmg aez9mn
12 Aug 24
Prospectus update (post-effective amendment)
5:23pm
6-K
EX-99.3
volcg
31 Jul 24
Common Stock Purchase Agreement
4:11pm
6-K
EX-99.1
a78rglf1v2xr
31 Jul 24
Common Stock Purchase Agreement
4:11pm
6-K
c57ogkd
31 Jul 24
Common Stock Purchase Agreement
4:11pm
6-K
EX-99.2
jwnlmn tru
31 Jul 24
Common Stock Purchase Agreement
4:11pm
6-K
EX-99.4
olupizgwwa kx
24 Jul 24
Current report (foreign)
4:35pm
6-K
EX-99.1
nt44 oszc84
5 Jul 24
Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
6:03am
F-1/A
i9yj5
6 May 24
Registration statement (foreign) (amended)
8:27pm
F-1/A
xxzdwy7b2z4dqsip
18 Apr 24
Registration statement (foreign) (amended)
6:03am
F-1/A
EX-10.17
dugnod3m3m706zdp35
18 Apr 24
Registration statement (foreign) (amended)
6:03am